fda glp-1 compounding crackdown september 2025 Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about compounded medications It's Time to Put Guardrails

K.LimY.KimJ

Although the mechanisms whereby TNBS cause an inflammatory response are not completely defined, this response is thought to be initiated by macrophage-mediated recognition and degradation of the TNBS-modified cells and proteins within the colonic interstitium (Grisham et al, 1991

But we found this story to be so compelling that we opted to publish this part of the story now

Semaglutide showed cardiovascular outcome improvements in the SELECT trial (in non-diabetic overweight and obese patients), and tirzepatide showed similar benefits in the SURMOUNT-MMO trial

B 12 deficiency can also result in neurological problems